F020 JAAD and Beyond: The Best Articles of the Year
DESCRIPTION
Cutting-edge advances published in JAAD, JAMA Derm, EADV and BJD will be presented with a discussion of why they are game changers.
LEARNING OBJECTIVES
Review treatment updates from the JAAD, JAMA Derm, EADV and BJD.
Discuss diagnostic updates from the JAAD, JAMA Derm, EADV and BJD.
SCHEDULE
1:00 PM
Best articles from JAMA Derm
Kanade Shinkai, MD, PhD, FAAD
1:15 PM
Best articles from JAAD Case Reports
Abby S. Van Voorhees, MD, FAAD
1:30 PM
The Best of JEADV
1:45 PM
Best articles from IJD
Lajos Kemeny, PhD, MD, DSc, IFAAD
2:00 PM
Best articles from JAAD International
Jonathan Kantor, MD, FAAD
2:15 PM
Best articles from BJD
Aaron Mark Drucker, MD, FAAD
2:30 PM
Best articles from JAAD Reviews
Shari Lipner, MD, PhD, FAAD
2:45 PM
Best articles from JAAD
Dirk Michael Elston, MD, FAAD
DIRECTOR
Dirk Michael Elston, MD, FAAD
SPEAKERS
Aaron Mark Drucker, MD, FAAD
Jonathan Kantor, MD, FAAD
Lajos Kemeny, PhD, MD, DSc, IFAAD
Shari Lipner, MD, PhD, FAAD
Kanade Shinkai, MD, PhD, FAAD
Abby S. Van Voorhees, MD, FAAD
DISCLOSURES
Aaron Mark Drucker, MD, FAAD
No financial relationships exist with ineligible companies.
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Jonathan Kantor, MD, FAAD
McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); PellePharm, Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);
Lajos Kemeny, PhD, MD, DSc, IFAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Eli-Lilly – Advisory Board(Honoraria); Eli-Lilly Ltd – Advisory Board(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria);
Shari Lipner, MD, PhD, FAAD
BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);
Kanade Shinkai, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Abby S. Van Voorhees, MD, FAAD
Eluciderm – Consultant (1099 relationship)(No Compensation Received); Merck & Co., Inc – Other(Other Financial Benefit);